Method or Molecule: Judge Dyk Dissents from En Banc Denial in Teva v. Lilly
Federal Circuit denies en banc review in Teva v. Lilly over Judge Dyk's dissent, leaving method claims to an antibody genus intact after Amgen.
Federal Circuit denies en banc review in Teva v. Lilly over Judge Dyk's dissent, leaving method claims to an antibody genus intact after Amgen.